This inventor holds 1 USPTO granted patent. Top assignees: Korea Advanced Institute of Science and Technology, Labgenomics Co., Ltd.. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2016
Title: Hyo Won Park: Innovator in Genitourinary Infection Diagnosis
Introduction
Hyo Won Park is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of medical diagnostics, particularly in the area of genitourinary infections. His innovative work has the potential to enhance the accuracy and efficiency of diagnosing these infections.
Latest Patents
Hyo Won Park holds a patent for a DNA chip designed for the diagnosis of genitourinary infections. This DNA chip is equipped with oligonucleotide probes that can detect fourteen different pathogens associated with genitourinary infections. The technology allows for rapid and precise analysis of infections, including the ability to identify multiple infections from various samples. The DNA chip is characterized by its high sensitivity, specificity, and reproducibility, making it a valuable tool for primary health care institutions in diagnosing and treating genitourinary infections.
Career Highlights
Throughout his career, Hyo Won Park has been associated with prominent institutions such as the Korea Advanced Institute of Science and Technology and Labgenomics Co., Ltd. His work in these organizations has contributed to advancements in medical technology and diagnostics.
Collaborations
Hyo Won Park has collaborated with several professionals in his field, including Hyun Gyu Park and Ye Lim Jung. These collaborations have fostered innovation and development in the area of medical diagnostics.
Conclusion
Hyo Won Park's contributions to the field of genitourinary infection diagnosis through his patented DNA chip exemplify the impact of innovative thinking in healthcare. His work continues to pave the way for improved diagnostic methods and better patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile